Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05798897 |
| Title | Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma (APOLLO) |
| Acronym | APOLLO |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Marker Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | RECRUITING | Duarte | California | 91010 | United States | Details |
| Colorado Blood Cancer Institute (Sarah Cannon) | RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Tennessee Oncology PLLC | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| Sarah Cannon Research Institute at St. David's South Austin | RECRUITING | Austin | Texas | 78704 | United States | Details |